Real-world treatment patterns and clinical outcomes in Er+/Her2- metastatic breast cancer

Results from a multicountry retrospective medical record review

Mitra, D., Kurosky, S., Zanotti, G., & Kaye, J. (2016). Real-world treatment patterns and clinical outcomes in Er+/Her2- metastatic breast cancer: Results from a multicountry retrospective medical record review. Value in Health, 19(3), A137. https://doi.org/10.1016/j.jval.2016.03.1644

Abstract

Although ET is the recommended treatment for most patients with ER+/HER2– MBC, a substantial proportion received CT, possibly due to the high prevalence of visceral disease in the study population. Median TTP on current therapies is < 1 year. These findings suggest a continuing unmet need for new treatments that extend TTP.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis
Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Spatiotemporal analysis exploring the effect of law enforcement drug market disruptions on overdose, Indianapolis, Indiana, 2020-2021
Article

Protocol for the formative phase of a trial (SHE-CAN) to test co-designed implementation strategies for HPV-based cervical screening among vulnerable women in two diverse settings in India